Opposing effects of cannabidiol in patient-derived neuroendocrine tumor, pheochromocytoma/paraganglioma primary cultures.
Katharina WangLaura SchoberAlessa FischerNicole BechmannJulian MaurerLea PeischerAstrid ReulConstanze HantelMartin ReinckeFelix BeuschleinMercedes RobledoHermine MohrNatalia S PellegataKatharina SchilbachThomas KnöselMatthias IlmerMartin AngeleMatthias KroissUmberto MaccioMartina Broglie-DäppenDiana VetterKuno LehmannKarel PacakAshley B GrossmanChristoph J AuernhammerKathrin ZitzmannSvenja NöltingPublished in: The Journal of clinical endocrinology and metabolism (2024)
We suggest a potential novel treatment option for some NETs/PPGLs, but also provide evidence for caution when applying cannabinoids as supportive therapy for pain or appetite management to cancer patients, and possibly as health supplements.